Recent discussions on X about Accenture (ACN) have been ignited by the company’s ambitious plan to train over 700,000 employees in agentic AI, a move aimed at meeting growing enterprise demand for advanced AI solutions. Many users are intrigued by this initiative, seeing it as a potential game-changer for Accenture’s position in the competitive tech services market. The buzz reflects curiosity about how this could impact the company’s future growth and client offerings.
However, not all chatter is purely optimistic, as some posts on X also highlight analyst downgrades, with price targets being lowered by prominent firms, stirring concerns about near-term stock performance. There’s a notable divide among users, with some focusing on long-term strategic benefits of AI investment, while others express caution over current market challenges facing the company. This mix of perspectives keeps the conversation lively and dynamic.
Note: This discussion summary was generated from an AI condensation of post data.
Accenture Congressional Stock Trading
Members of Congress have traded $ACN stock 13 times in the past 6 months. Of those trades, 2 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $ACN stock by members of Congress over the last 6 months:
- REPRESENTATIVE KELLY MORRISON has traded it 5 times. They made 0 purchases and 5 sales worth up to $145,000 on 08/19.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/24 and 1 sale worth up to $15,000 on 07/10.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $50,000 on 04/08.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/31.
- REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 03/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Accenture Insider Trading Activity
Accenture insiders have traded $ACN stock on the open market 47 times in the past 6 months. Of those trades, 0 have been purchases and 47 have been sales.
Here’s a breakdown of recent trading of $ACN stock by insiders over the last 6 months:
- JULIE SPELLMAN SWEET (Chair and CEO) has made 0 purchases and 11 sales selling 4,535 shares for an estimated $1,279,043.
- JOEL UNRUCH (General Counsel/Corp Secretary) has made 0 purchases and 7 sales selling 3,563 shares for an estimated $1,003,969.
- JOHN F WALSH (Chief Operating Officer) sold 2,500 shares for an estimated $812,500
- MAURO MACCHI (Chief Executive Officer-EMEA) has made 0 purchases and 11 sales selling 1,500 shares for an estimated $433,138.
- ANGIE Y PARK (Chief Financial Officer) sold 1,250 shares for an estimated $377,950
- MANISH SHARMA (CEO-The Americas) has made 0 purchases and 6 sales selling 962 shares for an estimated $270,886.
- ANGELA BEATTY (Chief Leadership & HR Officer) has made 0 purchases and 10 sales selling 372 shares for an estimated $104,956.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Accenture Hedge Fund Activity
We have seen 1,099 institutional investors add shares of Accenture stock to their portfolio, and 1,299 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SANDERS CAPITAL, LLC added 8,824,786 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,637,640,287
- CAPITAL INTERNATIONAL INVESTORS added 5,014,172 shares (+70.3%) to their portfolio in Q2 2025, for an estimated $1,498,685,869
- GAMMA INVESTING LLC removed 3,409,689 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $1,019,121,945
- JPMORGAN CHASE & CO removed 2,431,178 shares (-33.4%) from their portfolio in Q2 2025, for an estimated $726,654,792
- VICTORY CAPITAL MANAGEMENT INC added 1,407,752 shares (+438.4%) to their portfolio in Q2 2025, for an estimated $420,762,995
- UBS GROUP AG added 1,380,530 shares (+49.3%) to their portfolio in Q2 2025, for an estimated $412,626,611
- VANGUARD GROUP INC added 1,315,548 shares (+2.1%) to their portfolio in Q2 2025, for an estimated $393,204,141
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Accenture Government Contracts
We have seen $2,849,098,671 of award payments to $ACN over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- FEDERALLY FACILITATED EXCHANGE (FFE): $192,128,294
- THIS TASK ORDER IS FOR AN ENTERPRISE-WIDE DIGITAL AND CUSTOMER CARE PLATFORMS AND SERVICES SOLUTION (ENTERP...: $124,213,364
- AWARD FOR UNIFIED ENTERPRISE RESOURCE PLANNING CAPABILITY SUPPORT SERVICES: $115,762,026
- VBA DGIB SUPPORT SERVICES PURCHASE: $106,992,946
- BPA ORDER 34, CONSOLIDATED SUPPORT SERVICES/ITIL ALIGNMENT ISSUED UNDER MASTER BPA NUMBER 89303019AIM000005: $101,516,985
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Accenture Analyst Ratings
Wall Street analysts have issued reports on $ACN in the last several months. We have seen 10 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 09/09/2025
- JP Morgan issued a "Overweight" rating on 08/20/2025
- HSBC issued a "Reduce" rating on 07/28/2025
- Evercore ISI Group issued a "Outperform" rating on 07/17/2025
- Mizuho issued a "Outperform" rating on 06/24/2025
- Guggenheim issued a "Buy" rating on 06/23/2025
- Barclays issued a "Overweight" rating on 06/23/2025
To track analyst ratings and price targets for Accenture, check out Quiver Quantitative's $ACN forecast page.
Accenture Price Targets
Multiple analysts have issued price targets for $ACN recently. We have seen 16 analysts offer price targets for $ACN in the last 6 months, with a median target of $327.5.
Here are some recent targets:
- Nate Svensson from Deutsche Bank set a target price of $260.0 on 09/11/2025
- Bryan Bergin from TD Cowen set a target price of $313.0 on 09/09/2025
- James Faucette from Morgan Stanley set a target price of $271.0 on 09/09/2025
- Harry Read from Rothschild & Co set a target price of $250.0 on 09/03/2025
- Tien-Tsin Huang from JP Morgan set a target price of $302.0 on 08/20/2025
- Phani Kanumuri from HSBC set a target price of $240.0 on 07/28/2025
- David Togut from Evercore ISI Group set a target price of $330.0 on 07/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
